OPTIMIZERx Corp (OPRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
OPTIMIZERx Corp stock (OPRX) is currently trading at $6.78. OPTIMIZERx Corp PE ratio is 23.81. OPTIMIZERx Corp PS ratio (Price-to-Sales) is 1.10. Analyst consensus price target for OPRX is $14.50. WallStSmart rates OPRX as Underperform.
- OPRX PE ratio analysis and historical PE chart
- OPRX PS ratio (Price-to-Sales) history and trend
- OPRX intrinsic value — DCF, Graham Number, EPV models
- OPRX stock price prediction 2025 2026 2027 2028 2029 2030
- OPRX fair value vs current price
- OPRX insider transactions and insider buying
- Is OPRX undervalued or overvalued?
- OPTIMIZERx Corp financial analysis — revenue, earnings, cash flow
- OPRX Piotroski F-Score and Altman Z-Score
- OPRX analyst price target and Smart Rating
OPTIMIZERx Corp
📊 No data available
Try selecting a different time range
OPRX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · OPTIMIZERx Corp (OPRX)
OPRX trades 402% above its Graham fair value of $1.84, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
OPTIMIZERx Corp (OPRX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
OPTIMIZERx Corp (OPRX) Key Strengths (4)
Trading below book value, meaning the market prices it less than net assets
74.37% of shares held by major funds and institutions
Strong operational efficiency: $28 kept per $100 revenue
Paying $1.10 for every $1 of annual revenue
Supporting Valuation Data
OPTIMIZERx Corp (OPRX) Areas to Watch (6)
Revenue declining -0.20%, a shrinking business
Earnings declining -66.80%, profits shrinking
Very low returns on shareholder equity
Very thin margins, barely profitable
Micro-cap company with very limited liquidity and high volatility
Growth is fairly priced, not cheap, not expensive
OPTIMIZERx Corp (OPRX) Detailed Analysis Report
Overall Assessment
This company scores 49/100 in our Smart Analysis, earning a D+ grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Institutional Own., Operating Margin. Valuation metrics including Price/Sales (1.10), Price/Book (0.88) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 27.70%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Return on Equity. Some valuation metrics including PEG Ratio (1.61) suggest expensive pricing. Growth concerns include Revenue Growth at -0.20%, EPS Growth at -66.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.18%, Profit Margin at 4.69%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.18% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -0.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
OPRX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
OPRX's Price-to-Sales ratio of 1.10x trades at a deep discount to its historical average of 141.8x (3th percentile). The current valuation is 100% below its historical high of 1625.3x set in Jan 2010, and 49% above its historical low of 0.74x in Feb 2008. Over the past 12 months, the PS ratio has compressed from ~1.7x as trailing revenue scaled faster than the stock price.
Compare OPRX with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for OPTIMIZERx Corp (OPRX) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
OPTIMIZERx Corp faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 109M with 20% decline year-over-year. Profit margins are strong at 469.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 418.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 469.0% and operating margin of 27.7% demonstrate strong pricing power and operational efficiency.
Revenue contracted 20% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact OPTIMIZERx Corp.
Bottom Line
OPTIMIZERx Corp faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About OPTIMIZERx Corp(OPRX)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
OptimizeRx Corporation is a digital health company providing communications solutions for life sciences companies, physicians, and patients. The company is headquartered in Rochester, Michigan.